Teladoc Health, Inc. (TDOC)
| Market Cap | 1.60B +21.0% |
| Revenue (ttm) | 2.47B -2.4% |
| Net Income | -154.82M |
| EPS | -0.86 |
| Shares Out | 182.29M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,158,264 |
| Open | 8.68 |
| Previous Close | 8.69 |
| Day's Range | 8.65 - 8.91 |
| 52-Week Range | 4.40 - 9.89 |
| Beta | 1.97 |
| Analysts | Hold |
| Price Target | 8.81 (+0.07%) |
| Earnings Date | Oct 28, 2026 |
About TDOC
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical services, specialty medical, chronic condition management, and mental health services, as well as technologies and enterprise telehealth solutions for hospitals and health systems. Its BetterHelp segment operates a mental health platform that provides online counselling and therapy services through we... [Read more]
Financial Performance
In 2025, Teladoc Health's revenue was $2.53 billion, a decrease of -1.54% compared to the previous year's $2.57 billion. Losses were -$200.32 million, -79.99% less than in 2024.
Financial StatementsAnalyst Summary
According to 23 analysts, the average rating for TDOC stock is "Hold." The 12-month stock price target is $8.81, which is an increase of 0.07% from the latest price.
News
Teladoc Health Canada Named Strategic Innovation Partner by NL Health Services to Advance Virtual Care Across the Province
TORONTO--(BUSINESS WIRE)--Teladoc Health Canada has been named a Strategic Innovation Partner by Newfoundland and Labrador Health Services (NLHS), building on an established collaboration to create ne...
Teladoc price target raised to $8 from $6 at TD Cowen
TD Cowen raised the firm’s price target on Teladoc (TDOC) to $8 from $6 and keeps a Hold rating on the shares. The firm updated its model following solid beat…
Teladoc price target raised to $9 from $7 at Barclays
Barclays analyst Peter Warendorf raised the firm’s price target on Teladoc (TDOC) to $9 from $7 and keeps an Equal Weight rating on the shares.
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to three new employees.
Teladoc downgraded to Sell from Hold at Argus
Argus analyst David Toung downgraded Teladoc (TDOC) to Sell from Hold.
Teladoc price target raised to $10 from $7 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised the firm’s price target on Teladoc (TDOC) to $10 from $7 and keeps an Outperform rating on the shares following Q3 results and 10-Q. Overall,…
Teladoc price target raised to $9 from $6.50 at UBS
UBS raised the firm’s price target on Teladoc (TDOC) to $9 from $6.50 and keeps a Neutral rating on the shares. The company’s Q3 report was positive on margins against…
Teladoc price target raised to $10 from $8 at JPMorgan
JPMorgan raised the firm’s price target on Teladoc (TDOC) to $10 from $8 and keeps a Neutral rating on the shares.
Teladoc price target raised to $6.50 from $5.50 at Stifel
Stifel raised the firm’s price target on Teladoc (TDOC) to $6.50 from $5.50 and keeps a Hold rating on the shares.
Teladoc Health Earnings Call Transcript: Q3 2026
Q3 revenue was $605M and adjusted EBITDA rose 13.5% YoY to $79M. BetterHelp insurance growth and Integrated Care strength supported results, while cash-pay pressure continues; 2026 guidance was raised and insurance scaling remains a priority.
Teladoc Health Earnings release: Q3 2026
Teladoc Health released its Q3 2026 earnings on October 28, 2026, summarizing the period's financial results.
Teladoc Health Slides: Q3 2026
Teladoc Health has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on October 28, 2026.
Teladoc Health Quarterly report: Q3 2026
Teladoc Health has published its Q3 2026 quarterly earnings report on October 28, 2026.
Teladoc Health Reports Third Quarter 2026 Results
NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2026 (“Third...
Teladoc Health to Announce Third Quarter 2026 Financial Results
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2026 results on Wednesday, October 28, 202...
Teladoc Health Expands Solo Connected Care Platform with AI-Powered Capabilities to Help Hospitals Scale Smarter Care Delivery
New SoloVitals and SoloScribe capabilities bring contactless vitals and ambient documentation directly into clinical workflows New SoloVitals and SoloScribe capabilities bring contactless vitals and a...
Teladoc announces resignation of CLO Vandervoort, Dorfman to succeed
Teladoc (TDOC) Health announced a leadership transition in its legal function. After 11 years with the company, Adam Vandervoort, Chief Legal Officer, CLO, and Secretary, has informed the company of…
Teladoc Health Announces Chief Legal Officer Transition
Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026 Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026
Teladoc appoints insurance executive Michael Grasher as CFO
Teladoc Health said on Monday it appointed Michael Grasher as its chief financial officer, bringing in an industry veteran to help the virtual healthcare company navigate rising demand for its insur...
Teladoc Health Appoints Michael Grasher as Chief Financial Officer
Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Teladoc Health...
Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby yo...
Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors
NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquill...
Teladoc tumbles on revenue forecast cut as BetterHelp demand shifts hurt
Teladoc shares fell more than 20% before the bell on Thursday, a day after the virtual healthcare provider trimmed its annual revenue forecast and flagged challenges at its mental health services uni...
Teladoc Health Earnings Call Transcript: Q2 2026
Q2 results met guidance with Integrated Care outperforming and BetterHelp pressured by a rapid shift from cash pay to insurance, outpacing provider capacity. 2026 revenue guidance was lowered due to cash pay declines, but insurance revenue and margin guidance were reaffirmed. Teladoc One was launched as a new care model.
Teladoc Health Slides: Q2 2026
Teladoc Health has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.